AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…
Doctors Without Borders health workers in personal protective equipment move through the isolated red zone to monitor patients, provide medical…
The Food and Drug Administration on Tuesday authorized Philip MorrisZyn's proprietary Zyn nicotine pouches will be marketed as less harmful…
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
Wegovy weight loss treatment injectable pens, manufactured by Novo Nordisk A/S, on display during a press conference in Mumbai, India,…
Sheldon Cooper | Light rocket | fake images rye said it offered buyouts to some employees on Monday, as the…
Biohub, a nonprofit research organization funded by the Chan Zuckerberg Initiative, announced Thursday that it will open another round of…